News cyclin.
More is being learned about CDK12 and its role across a host of cancers. This retrospective look at over 25K patients undergoing tumor sequencing at MSKCC reports over 5% of prostate cancers harbor a CDK12 alteration portending more aggressive cancers and worse survival. | Nguyen, Eur Urol 2020
This is such a great resource that you are providing and you give it away for free. I love seeing blog that understand the value of providing a quality resource for free kubet
ReplyDelete